Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tasha Serna-Gallegos

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Opinion in Obstetrics & Gynecology|September 5, 2020
A lasting impression: telemedicine in urogynecology during the coronavirus disease 2019 pandemicTasha Serna-Gallegos, Cara S Ninivaggio
Obstetrics and Gynecology Clinics of North America|August 21, 2021
Female Pelvic FistulaeTasha Serna-Gallegos, Peter C Jeppson
Future Oncology (London, England)|November 25, 2015
A review of HER2-targeted therapy in breast and ovarian cancer: lessons from antiquity - CLEOPATRA and PENELOPEMelissa Hodeib, Tasha Serna-Gallegos, Krishnansu S Tewari
Gynecologic Oncology Reports|January 5, 2017
Cardiophrenic lymph node metastasis in low-grade serous ovarian adenocarcinomaTasha Serna-Gallegos, Nicolas Gallegos, Robert E Bristow
Case Reports in Women'S Health|March 11, 2020
A ruptured vulvar labial artery pseudoaneurysm causes a secondary postpartum hemorrhage: A case reportMarie-Claire Leaf, Luke Schmidt, Tasha Serna-Gallegos, et al.
Urogynecology (Philadelphia, Pa.)|June 16, 2023
Risk Factors for De Novo Overactive Bladder After Midurethral SlingTasha Serna-Gallegos, Sonia Dutta, Carly Crowder, et al.
Urogynecology (Philadelphia, Pa.)|February 3, 2023
Factors Associated With Increased Estimated Blood Loss and Factors Associated With Utilization of Type and Screen in Benign Gynecology: A Retrospective Chart ReviewSierra M Jansen, Desna Ghatalia, Alyssa Mayo, et al.
Gynecologic Oncology|February 16, 2020
Erratum to "Evaluation of clear cell subtypes of ovarian and uterine malignancies with anti-PD-L1 and anti-PD1 immunohistochemical expression and their association with stage and survival" [Gynecol. Oncol. 155 (2019) 483-488]Jill Alldredge, Tasha Serna-Gallegos, Nicolas Gallegos, et al.
Gynecologic Oncology|October 27, 2019
Evaluation of clear cell subtypes of ovarian and uterine malignancies with anti-PD-L1 and anti-PD1 immunohistochemical expression and their association with stage and survivalJill Alldredge, Tasha Serna-Gallegos, Nicolas Gallegos, et al.
Health|November 14, 2013
ATP Binding Cassette C1 (ABCC1/MRP1)-mediated drug efflux contributes to disease progression in T-lineage acute lymphoblastic leukemiaStuart S Winter, Jerec Ricci, Li Luo, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Opinion in Obstetrics & Gynecology|September 5, 2020
A lasting impression: telemedicine in urogynecology during the coronavirus disease 2019 pandemicTasha Serna-Gallegos, Cara S Ninivaggio
Obstetrics and Gynecology Clinics of North America|August 21, 2021
Female Pelvic FistulaeTasha Serna-Gallegos, Peter C Jeppson
Future Oncology (London, England)|November 25, 2015
A review of HER2-targeted therapy in breast and ovarian cancer: lessons from antiquity - CLEOPATRA and PENELOPEMelissa Hodeib, Tasha Serna-Gallegos, Krishnansu S Tewari
Gynecologic Oncology Reports|January 5, 2017
Cardiophrenic lymph node metastasis in low-grade serous ovarian adenocarcinomaTasha Serna-Gallegos, Nicolas Gallegos, Robert E Bristow
Case Reports in Women'S Health|March 11, 2020
A ruptured vulvar labial artery pseudoaneurysm causes a secondary postpartum hemorrhage: A case reportMarie-Claire Leaf, Luke Schmidt, Tasha Serna-Gallegos, et al.
Urogynecology (Philadelphia, Pa.)|June 16, 2023
Risk Factors for De Novo Overactive Bladder After Midurethral SlingTasha Serna-Gallegos, Sonia Dutta, Carly Crowder, et al.
Urogynecology (Philadelphia, Pa.)|February 3, 2023
Factors Associated With Increased Estimated Blood Loss and Factors Associated With Utilization of Type and Screen in Benign Gynecology: A Retrospective Chart ReviewSierra M Jansen, Desna Ghatalia, Alyssa Mayo, et al.
Gynecologic Oncology|February 16, 2020
Erratum to "Evaluation of clear cell subtypes of ovarian and uterine malignancies with anti-PD-L1 and anti-PD1 immunohistochemical expression and their association with stage and survival" [Gynecol. Oncol. 155 (2019) 483-488]Jill Alldredge, Tasha Serna-Gallegos, Nicolas Gallegos, et al.
Gynecologic Oncology|October 27, 2019
Evaluation of clear cell subtypes of ovarian and uterine malignancies with anti-PD-L1 and anti-PD1 immunohistochemical expression and their association with stage and survivalJill Alldredge, Tasha Serna-Gallegos, Nicolas Gallegos, et al.
Health|November 14, 2013
ATP Binding Cassette C1 (ABCC1/MRP1)-mediated drug efflux contributes to disease progression in T-lineage acute lymphoblastic leukemiaStuart S Winter, Jerec Ricci, Li Luo, et al.
Pageof 2